Phytochemicals as Regulators of Genes Involved in Synucleinopathies
Synucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein aggregates in neurons, nerve fibers or glial cells. Three main types of diseases belong to the synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy....
Main Authors: | Andrei Surguchov, Libby Bernal, Alexei A. Surguchev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/5/624 |
Similar Items
-
Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01) -
Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits
by: Wouter Peelaerts, et al.
Published: (2020-11-01) -
Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies
by: Cristine Betzer, et al.
Published: (2018-11-01) -
Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
by: Miguel Lemos, et al.
Published: (2020-09-01) -
A New Rise of Non-Human Primate Models of Synucleinopathies
by: Margaux Teil, et al.
Published: (2021-03-01)